Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950135-09-004064
Filing Date
2009-05-15
Accepted
2009-05-15 16:26:38
Documents
6
Period of Report
2009-03-31

Document Format Files

Seq Description Document Type Size
1 OXIGENE, INC. b75225oie10vq.htm 10-Q 251083
2 EX-10.1 OFFICE LEASE AGREEMENT, DATED APRIL 21, 2009 b75225oiexv10w1.htm EX-10.1 200023
3 EX-31.1 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER b75225oiexv31w1.htm EX-31.1 5889
4 EX-31.2 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER b75225oiexv31w2.htm EX-31.2 5914
5 EX-32.1 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER b75225oiexv32w1.htm EX-32.1 3970
6 GRAPHIC b75225oib7522501.gif GRAPHIC 44807
  Complete submission text file 0000950135-09-004064.txt   530059
Mailing Address
Business Address 321 ARSENAL STREET WATERTOWN MA 02472 6176737800
OXIGENE INC (Filer) CIK: 0000908259 (see all company filings)

IRS No.: 133679168 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-21990 | Film No.: 09833519
SIC: 2836 Biological Products, (No Diagnostic Substances)